A phase II investigator-initiated pilot study with low-dose cyclosporine A for the treatment of articular involvement in primary Sjögren’s syndrome
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A phase II investigator-initiated pilot study with low-dose cyclosporine A for the treatment of articular involvement in primary Sjögren’s syndrome
Authors
Keywords
Articular involment, Arthrosonography, Cyclosporine A, ESSDAI, EULAR, Primary Sjögren’s syndrome
Journal
CLINICAL RHEUMATOLOGY
Volume 35, Issue 9, Pages 2203-2210
Publisher
Springer Nature
Online
2016-07-28
DOI
10.1007/s10067-016-3360-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- How are we treating our systemic patients with primary Sjögren syndrome? Analysis of 1120 patients
- (2015) H. Gheitasi et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study)
- (2014) P M Meiners et al. ANNALS OF THE RHEUMATIC DISEASES
- Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)
- (2014) Raphaèle Seror et al. ANNALS OF THE RHEUMATIC DISEASES
- Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)
- (2014) Raphaèle Seror et al. ANNALS OF THE RHEUMATIC DISEASES
- Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis
- (2014) Baodong Qin et al. ANNALS OF THE RHEUMATIC DISEASES
- Oral involvement in primary Sjögren syndrome
- (2014) Philip C. Fox et al. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION
- Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study
- (2013) Xavier Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- Primary Sjögren syndrome: an update on current pharmacotherapy options and future directions
- (2013) Pilar Brito-Zerón et al. EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study
- (2013) Francesco Carubbi et al. ARTHRITIS RESEARCH & THERAPY
- Measures of functional status and quality of life in rheumatoid arthritis: Health Assessment Questionnaire Disability Index (HAQ), Modified Health Assessment Questionnaire (MHAQ), Multidimensional Health Assessment Questionnaire (MDHAQ), Health Assessment
- (2011) Leann Maska et al. ARTHRITIS CARE & RESEARCH
- Measures of fatigue: Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF MDQ), Bristol Rheumatoid Arthritis Fatigue Numerical Rating Scales (BRAF NRS) for Severity, Effect, and Coping, Chalder Fatigue Questionnaire (CFQ), Checklist
- (2011) Sarah Hewlett et al. ARTHRITIS CARE & RESEARCH
- Treatment of Primary Sjögren Syndrome
- (2010) Manuel Ramos-Casals et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome
- (2009) R. Seror et al. ANNALS OF THE RHEUMATIC DISEASES
- Primary Sjögren Syndrome in Spain
- (2009) Manuel Ramos-Casals et al. MEDICINE
- The Disease Activity Score and the EULAR Response Criteria
- (2009) Jaap Fransen et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started